IP Library Granted Patent US 12,414,865
Granted Patent B2
US 12,414,865 · App. 18/732,165 · Granted Sep 16, 2025

Implant trial with radiographically visible indicium

Inventors: Adam MacMillan (Quincy, MA); Gerhart Suppiger (St. Louis, MO); Brett Smith (St. Louis, MO)
Assignee: CORELINK, LLC
A61F2/4684A61F2/442A61F2002/3008A61F2002/30617
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,865
App. No.
18/732,165
Granted
Sep 16, 2025
Kind
B2
Abstract

An implant trial includes a trial body and an indicium disposed in the trial body. The trial body is positionable in a subject. The indicium is designed and constructed to indicate a parameter of the implant trial. The indicium is radiographically visible when the trial body is positioned in the subject. The implant trial may be a trial spacer for vertebrae.

Claims (23)

1. A trial spacer comprising:

a spacer body configured to be positioned between vertebrae of a subject, the spacer body having opposite proximal and distal ends, and opposite anterior and posterior sides;

depth indicia disposed in the spacer body, each of the depth indicia comprising a numerical value indicating a distance proximal from the distal end of the spacer body to a corresponding one of the depth indicia, wherein the depth indicia are radiographically visible when the spacer body is positioned between the vertebrae of the subject; and

a sizing indicium disposed in the spacer body, the sizing indicium comprising a numerical value to indicate a size of the trial spacer, wherein the sizing indicium is radiographically visible and readable when the spacer body is positioned between the vertebrae of the subject,

wherein the depth indicia are proximal of the sizing indicium so that the sizing indicium is intermediate the distal end of the spacer body and the depth indicia.

2. The trial spacer set forth in claim 1 , wherein the spacer body defines an internal chamber, wherein the depth indicia are is disposed in the internal chamber.

3. The trial spacer set forth in claim 1 , wherein each of the depth indicia is designed and constructed to be visible when radiographically viewed in an anterior-posterior view.

4. The trial spacer set forth in claim 3 , wherein the sizing indicium is designed and constructed to be visible when radiographically viewed in an anterior-posterior view.

5. The trial spacer set forth in claim 4 , wherein the sizing indicium is visible without radiographic imaging.

6. The trial spacer set forth in claim 1 , wherein the spacer body defines a window extending through the spacer body, wherein the sizing indicium is visible through the window without radiographic imaging.

7. The trial spacer set forth in claim 1 , wherein the depth indicia is enclosed within the spacer body, wherein a portion of the spacer body is more radiolucent than the depth indicia so that the depth indicia is radiographically visible.

8. The trial spacer set forth in claim 1 , wherein the spacer body includes a superior wall, an inferior wall, an anterior wall defining the anterior side, and a posterior wall defining the posterior side, wherein the depth indicia is radiographically visible through at least one of the anterior wall and the posterior wall.

9. The trial spacer set forth in claim 1 , further comprising depth markers on the spacer body, wherein each depth indicia corresponds to one of the depth markers.

10. A method of making a trial spacer of claim 1 , the method comprising forming the spacer body, the depth indicia, and the sizing indicium as an integrally formed, one-piece component by additive manufacturing.

11. A trial spacer comprising:

a spacer body configured to be positioned between vertebrae of a subject, the spacer body having opposite proximal and distal ends, and opposite anterior and posterior sides;

a first indicium disclosed within the spacer body and indicating a first parameter of the spacer body, the first indicium comprising a numerical value, wherein the first indicium is radiographically visible in a posterior-anterior direction when the spacer body is positioned between the vertebrae of the subject; and

a second indicium disposed in the spacer body and indicating a second parameter of the spacer body, the second indicium comprising a numerical value, wherein the second indicium is radiographically visible in a posterior-anterior direction when the spacer body is positioned between the vertebrae of the subject; and

wherein the first indicium is proximal of the second indicium so that the second indicium is intermediate the distal end of the spacer body and the first indicium.

12. The trial spacer set forth in claim 11 , wherein the second indicium is visible without radiographic imaging.

13. The trial spacer set forth in claim 12 , wherein a portion of the spacer body is more radiolucent than the first indicium so that the first indicium is radiographically visible.

14. The trial spacer set forth in claim 13 , wherein the spacer body includes a superior wall, and inferior wall, an anterior wall defining the anterior side, and a posterior wall defining the posterior side, wherein the first indicium is radiographically visible through at least one of the anterior wall and the posterior wall.

15. The trial spacer set forth in claim 14 , wherein the first indicium is only visible radiographically.

Assignments (2)
SECURITY INTEREST Recorded Feb 9, 2026
From: CORELINK, LLC
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 073738/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2024
From: MCMILLAN, ADAM; SUPPIGER, GERHART; SMITH, BRETT
To: CORELINK, LLC
Reel/Frame 067707/0126 →
Continuity (3)
Continuation 17308725 · May 5, 2021
Provisional Application 63020126 · May 5, 2020
Related Publication 20250073048A1 · Mar 6, 2025
References Cited (25)
US 6113639A · Ray · 2000 [cited by examiner]
US 6562041B1 · Yonemura · 2003 [cited by examiner]
US 6641582B1 · Hanson · 2003 [cited by examiner]
US 9801732B2 · Chin · 2017 [cited by examiner]
US 20030135275A1 · Garcia · 2003 [cited by examiner]
US 20030139813A1 · Messerli · 2003 [cited by examiner]
US 20030233145A1 · Landry · 2003 [cited by examiner]
US 20040019356A1 · Fraser · 2004 [cited by examiner]
US 20040052333A1 · Sayre et al. · 2004 [cited by applicant]
US 20040059337A1 · Hanson · 2004 [cited by examiner]
US 20060129238A1 · Paltzer · 2006 [cited by examiner]
US 20070093825A1 · Ferree · 2007 [cited by examiner]
US 20070237307A1 · Suddaby · 2007 [cited by examiner]
US 20080287959A1 · Quest · 2008 [cited by examiner]
US 20130331850A1 · Bojarski · 2013 [cited by examiner]
US 20140114415A1 · Tyber · 2014 [cited by examiner]
US 20140243982A1 · Miller · 2014 [cited by examiner]
US 20150223907A1 · Kieser · 2015 [cited by examiner]
US 20150328005A1 · Padovani et al. · 2015 [cited by applicant]
US 20150342757A1 · Lomeli · 2015 [cited by examiner]
US 20190298546A1 · Dewey · 2019 [cited by examiner]
US 20210290410A1 · Schumacher · 2021 [cited by examiner]
EP 1384455A1 · 2004 [cited by applicant]
WO WO2005072659A2 · 2005 [cited by applicant]
WO WO2014151172A1 · 2014 [cited by applicant]